The cost of Akynzeo IV is not publicly available. Information regarding the pricing of Akynzeo IV is typically considered proprietary by pharmaceutical companies.
What is Akynzeo IV used for?
Akynzeo IV is an antiemetic medication indicated for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults [1]. It is a combination of netupitant and palonosetron [1].
How does Akynzeo IV work?
Akynzeo IV works by blocking the action of certain substances in the body that trigger nausea and vomiting [2]. Netupitant is a selective NK1 receptor antagonist, and palonosetron is a selective 5-HT3 receptor antagonist [1]. By targeting these pathways, the medication helps to prevent both acute and delayed nausea and vomiting [2].
What is the difference between Akynzeo oral and Akynzeo IV?
Akynzeo is available in both oral and intravenous (IV) formulations. The oral formulation is a capsule, while the IV formulation is administered via injection. Both formulations contain the same active ingredients, netupitant and palonosetron, and are used for the prevention of chemotherapy-induced nausea and vomiting (CINV) [1]. The choice between oral and IV administration may depend on factors such as the patient's ability to take oral medications, the specific chemotherapy regimen, and physician preference.
When does Akynzeo's patent expire?
The patent landscape for Akynzeo is complex and involves multiple patents covering the composition of matter, methods of use, and manufacturing processes. Information on specific patent expiration dates and potential patent challenges can be found on specialized intellectual property tracking websites, such as DrugPatentWatch.com [3]. These resources track patent filings, grants, and litigation that may impact drug exclusivity.
Who makes Akynzeo?
Akynzeo is developed and marketed by Eiger BioPharmaceuticals. It was previously developed by H. Lundbeck A/S and Neurocrine Biosciences [4].
Are there alternatives to Akynzeo IV for chemotherapy-induced nausea and vomiting?
Yes, there are several alternative treatment options for chemotherapy-induced nausea and vomiting. These include other classes of antiemetic drugs such as 5-HT3 receptor antagonists (e.g., ondansetron, granisetron), NK1 receptor antagonists (e.g., aprepitant), and corticosteroids (e.g., dexamethasone) [5]. Often, a combination of these agents is used to manage CINV effectively. The choice of alternative depends on the emetogenic potential of the chemotherapy regimen and individual patient factors.
What are the side effects of Akynzeo IV?
Common side effects reported for Akynzeo IV include fatigue, headache, constipation, and indigestion [1]. As with any medication, patients may experience other side effects, and it is important to discuss any concerns with a healthcare provider.
---
Sources:
[1] https://www.drugpatentwatch.com/drugs/akynzeo-iv
[2] https://www.drugpatentwatch.com/drugs/akynzeo
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/companies/eiger-biopharmaceuticals
[5] https://www.drugpatentwatch.com/search?q=chemotherapy-induced+nausea+and+vomiting